Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases
Diverse liver diseases are characterised by late diagnosis and rapid progression and have become one of the major threats to human health. To delay the transition from benign tissue lesions to a substantial organ injury, scientists have gradually applied natural compounds derived from plants as a co...
Saved in:
Main Authors: | Mingyu Wu, Ke Li, Jiabin Wu, Xianyi Ding, Xiaotong Ma, Wenhong Wang, Weihua Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661824005164 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
by: Mingchun Jiang, et al.
Published: (2025-02-01) -
Role of ginsenoside Rg1 as a PPAR-γ activator in protecting against manganese-induced hepatotoxicity: Insights into the TLR4/MyD88/MAPK signaling pathway
by: Mengjing Zhao, et al.
Published: (2025-01-01) -
Ginsenoside Rg1 alleviates chronic testicular damage caused by cranial irradiation through the SCF/PI3K/Akt/mTOR pathway in mice
by: Qiuhua Zhou, et al.
Published: (2025-02-01) -
Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases
by: Jialian Lv, et al.
Published: (2025-02-01) -
Effects of straw amendment on the bioavailability of selenite in soil and its mechanisms
by: Mingxing Qi, et al.
Published: (2025-01-01)